- call +1-201-465-4211
- email sales@mrinsights.biz
Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Scope of the Report:
This report focuses on the Asthma & COPD in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
The worldwide market for Asthma & COPD is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs
Market Segment by Applications, can be divided into
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
There are 15 Chapters to deeply display the global Asthma & COPD market.
Chapter 1, to describe Asthma & COPD Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Asthma & COPD, with sales, revenue, and price of Asthma & COPD, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Asthma & COPD, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Asthma & COPD market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Asthma & COPD sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Asthma & COPD Introduction
1.2 Market Analysis by Type
1.2.1 Anti-inflammatory Drugs
1.2.2 Bronchodilator Monotherapy
1.2.3 Combination Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Private Clinics
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Asthma & COPD Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Asthma & COPD Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Asthma & COPD Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott
2.4.1 Business Overview
2.4.2 Asthma & COPD Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Asthma & COPD Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Asthma & COPD Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 Asthma & COPD Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva
2.8.1 Business Overview
2.8.2 Asthma & COPD Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Vectura
2.9.1 Business Overview
2.9.2 Asthma & COPD Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Vectura Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Asthma & COPD Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Mylan
2.11.1 Business Overview
2.11.2 Asthma & COPD Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mylan Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Allergan
2.12.1 Business Overview
2.12.2 Asthma & COPD Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Allergan Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Cipla
2.13.1 Business Overview
2.13.2 Asthma & COPD Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Cipla Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Akorn
2.14.1 Business Overview
2.14.2 Asthma & COPD Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Akorn Asthma & COPD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Asthma & COPD Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Asthma & COPD Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Asthma & COPD Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Asthma & COPD Manufacturer Market Share in 2017
3.3.2 Top 6 Asthma & COPD Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Asthma & COPD Market Analysis by Regions
4.1 Global Asthma & COPD Sales, Revenue and Market Share by Regions
4.1.1 Global Asthma & COPD Sales and Market Share by Regions (2013-2018)
4.1.2 Global Asthma & COPD Revenue and Market Share by Regions (2013-2018)
4.2 North America Asthma & COPD Sales and Growth Rate (2013-2018)
4.3 Europe Asthma & COPD Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Asthma & COPD Sales and Growth Rate (2013-2018)
4.5 South America Asthma & COPD Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Asthma & COPD Sales and Growth Rate (2013-2018)
5 North America Asthma & COPD by Countries
5.1 North America Asthma & COPD Sales, Revenue and Market Share by Countries
5.1.1 North America Asthma & COPD Sales and Market Share by Countries (2013-2018)
5.1.2 North America Asthma & COPD Revenue and Market Share by Countries (2013-2018)
5.2 United States Asthma & COPD Sales and Growth Rate (2013-2018)
5.3 Canada Asthma & COPD Sales and Growth Rate (2013-2018)
5.4 Mexico Asthma & COPD Sales and Growth Rate (2013-2018)
6 Europe Asthma & COPD by Countries
6.1 Europe Asthma & COPD Sales, Revenue and Market Share by Countries
6.1.1 Europe Asthma & COPD Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Asthma & COPD Revenue and Market Share by Countries (2013-2018)
6.2 Germany Asthma & COPD Sales and Growth Rate (2013-2018)
6.3 UK Asthma & COPD Sales and Growth Rate (2013-2018)
6.4 France Asthma & COPD Sales and Growth Rate (2013-2018)
6.5 Russia Asthma & COPD Sales and Growth Rate (2013-2018)
6.6 Italy Asthma & COPD Sales and Growth Rate (2013-2018)
7 Asia-Pacific Asthma & COPD by Countries
7.1 Asia-Pacific Asthma & COPD Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Asthma & COPD Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Asthma & COPD Revenue and Market Share by Countries (2013-2018)
7.2 China Asthma & COPD Sales and Growth Rate (2013-2018)
7.3 Japan Asthma & COPD Sales and Growth Rate (2013-2018)
7.4 Korea Asthma & COPD Sales and Growth Rate (2013-2018)
7.5 India Asthma & COPD Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Asthma & COPD Sales and Growth Rate (2013-2018)
8 South America Asthma & COPD by Countries
8.1 South America Asthma & COPD Sales, Revenue and Market Share by Countries
8.1.1 South America Asthma & COPD Sales and Market Share by Countries (2013-2018)
8.1.2 South America Asthma & COPD Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Asthma & COPD Sales and Growth Rate (2013-2018)
8.3 Argentina Asthma & COPD Sales and Growth Rate (2013-2018)
8.4 Colombia Asthma & COPD Sales and Growth Rate (2013-2018)
9 Middle East and Africa Asthma & COPD by Countries
9.1 Middle East and Africa Asthma & COPD Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Asthma & COPD Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Asthma & COPD Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Asthma & COPD Sales and Growth Rate (2013-2018)
9.3 UAE Asthma & COPD Sales and Growth Rate (2013-2018)
9.4 Egypt Asthma & COPD Sales and Growth Rate (2013-2018)
9.5 Nigeria Asthma & COPD Sales and Growth Rate (2013-2018)
9.6 South Africa Asthma & COPD Sales and Growth Rate (2013-2018)
10 Global Asthma & COPD Market Segment by Type
10.1 Global Asthma & COPD Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Asthma & COPD Sales and Market Share by Type (2013-2018)
10.1.2 Global Asthma & COPD Revenue and Market Share by Type (2013-2018)
10.2 Anti-inflammatory Drugs Sales Growth and Price
10.2.1 Global Anti-inflammatory Drugs Sales Growth (2013-2018)
10.2.2 Global Anti-inflammatory Drugs Price (2013-2018)
10.3 Bronchodilator Monotherapy Sales Growth and Price
10.3.1 Global Bronchodilator Monotherapy Sales Growth (2013-2018)
10.3.2 Global Bronchodilator Monotherapy Price (2013-2018)
10.4 Combination Drugs Sales Growth and Price
10.4.1 Global Combination Drugs Sales Growth (2013-2018)
10.4.2 Global Combination Drugs Price (2013-2018)
11 Global Asthma & COPD Market Segment by Application
11.1 Global Asthma & COPD Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Private Clinics Sales Growth (2013-2018)
11.4 Drug Stores Sales Growth (2013-2018)
11.5 Retail Pharmacies Sales Growth (2013-2018)
11.6 E-Commerce Sales Growth (2013-2018)
12 Asthma & COPD Market Forecast (2018-2023)
12.1 Global Asthma & COPD Sales, Revenue and Growth Rate (2018-2023)
12.2 Asthma & COPD Market Forecast by Regions (2018-2023)
12.2.1 North America Asthma & COPD Market Forecast (2018-2023)
12.2.2 Europe Asthma & COPD Market Forecast (2018-2023)
12.2.3 Asia-Pacific Asthma & COPD Market Forecast (2018-2023)
12.2.4 South America Asthma & COPD Market Forecast (2018-2023)
12.2.5 Middle East and Africa Asthma & COPD Market Forecast (2018-2023)
12.3 Asthma & COPD Market Forecast by Type (2018-2023)
12.3.1 Global Asthma & COPD Sales Forecast by Type (2018-2023)
12.3.2 Global Asthma & COPD Market Share Forecast by Type (2018-2023)
12.4 Asthma & COPD Market Forecast by Application (2018-2023)
12.4.1 Global Asthma & COPD Sales Forecast by Application (2018-2023)
12.4.2 Global Asthma & COPD Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Asthma & COPD Picture
Table Product Specifications of Asthma & COPD
Figure Global Sales Market Share of Asthma & COPD by Types in 2017
Table Asthma & CO
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
